ARIH2 and hepatocellular carcinoma: The nomogram was utilized to evaluate the relationship among the main treatment outcomes of HCC patients, such as ARIH2, Pathologic stage, Pathologic T stage, Pathologic M stage, and the 1-, 3-, and 5-year survival prognosis [C-index: 0.706 (0.667-0.744), Figure 6A].